Adjuvant chemotherapy for stage III colon cancer: does timing matter?

  title={Adjuvant chemotherapy for stage III colon cancer: does timing matter?},
  author={Piotr Marek Czaykowski and Sharlene Gill and Hagen Fritz Kennecke and Vallerie L Gordon and Donna Turner},
  journal={Diseases of the colon and rectum},
  volume={54 9},
BACKGROUND Clinical trials commonly mandate that adjuvant chemotherapy for colon cancer should commence within 8 weeks (56 days) of surgery. OBJECTIVE We investigated the consequences of the timing of adjuvant chemotherapy for stage III colon cancer. PATIENTS AND METHODS This is a retrospective review of all patients with newly diagnosed stage III colon cancer who received adjuvant chemotherapy in 2 provincial centers in 1999 and 2000. The impact of time to adjuvant chemotherapy on overall… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 25 extracted citations

Initiation of adjuvant chemotherapy within 8 weeks of elective colorectal resection improves overall survival regardless of reoperation.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland • 2016
View 2 Excerpts

Similar Papers

Loading similar papers…